Helen Sheridan
Corporate Officer/Principal bij Irish Medicines Board
Profiel
Helen Sheridan is the founder of Trino Therapeutics Ltd., which was founded in 1999.
She held the title of Principal Chemist & IP Specialist from 1999 to 2012.
Currently, she is a Member of the Irish Medicines Board.
Dr. Sheridan received a doctorate degree from University College Dublin.
Actieve functies van Helen Sheridan
Bedrijven | Functie | Begin |
---|---|---|
Irish Medicines Board | Corporate Officer/Principal | - |
Eerdere bekende functies van Helen Sheridan
Bedrijven | Functie | Einde |
---|---|---|
Trino Therapeutics Ltd.
Trino Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Trino Therapeutics Ltd. operates as a drug discovery and development company. It focuses on developing oral small molecules for the treatment and unmet management of inflammatory bowel disease and other inflammatory indications. The company was founded by Neil Howard Frankish and Helen Sheridan in 1999 and is headquartered in Dublin, Ireland. | Oprichter | - |
Opleiding van Helen Sheridan
University College Dublin | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Trino Therapeutics Ltd.
Trino Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Trino Therapeutics Ltd. operates as a drug discovery and development company. It focuses on developing oral small molecules for the treatment and unmet management of inflammatory bowel disease and other inflammatory indications. The company was founded by Neil Howard Frankish and Helen Sheridan in 1999 and is headquartered in Dublin, Ireland. | Health Technology |
Irish Medicines Board |